Ken Fisher's EXAS Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 198,287 shares of Exact Sciences Corporation (EXAS) worth $10.85 M, representing 0.00% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 69,367 shares. Largest reduction occurred in Q1 2023, reducing 46,318 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2017 | +6,350 | New Buy | 6,350 | $47.09 |
| Q1 2018 | -6,350 | Sold Out | 6,350 | $0.00 |
| Q2 2018 | +55,621 | New Buy | 55,621 | $59.80 |
| Q3 2018 | +430 | Add 0.77% | 56,051 | $78.93 |
| Q4 2018 | -400 | Reduce 0.71% | 55,651 | $63.11 |
| Q1 2019 | -4,272 | Reduce 7.68% | 51,379 | $86.61 |
| Q2 2019 | +16,771 | Add 32.64% | 68,150 | $118.03 |
| Q3 2019 | -2,110 | Reduce 3.10% | 66,040 | $90.37 |
| Q4 2019 | -41,985 | Reduce 63.58% | 24,055 | $92.50 |
| Q1 2020 | -7,722 | Reduce 32.10% | 16,333 | $57.98 |
| Q2 2020 | -318 | Reduce 1.95% | 16,015 | $86.92 |
| Q3 2020 | +387 | Add 2.42% | 16,402 | $101.94 |
| Q4 2020 | +4,972 | Add 30.31% | 21,374 | $132.50 |
| Q1 2021 | +4,579 | Add 21.42% | 25,953 | $131.78 |
| Q2 2021 | +2,163 | Add 8.33% | 28,116 | $124.31 |
| Q3 2021 | -2,747 | Reduce 9.77% | 25,369 | $95.43 |
| Q4 2021 | +15,511 | Add 61.14% | 40,880 | $77.84 |
| Q1 2022 | +508 | Add 1.24% | 41,388 | $69.92 |
| Q2 2022 | +69,367 | Add 167.60% | 110,755 | $39.39 |
| Q3 2022 | +12,596 | Add 11.37% | 123,351 | $32.49 |
| Q4 2022 | +35,542 | Add 28.81% | 158,893 | $49.51 |
| Q1 2023 | -46,318 | Reduce 29.15% | 112,575 | $67.81 |
| Q2 2023 | -511 | Reduce 0.45% | 112,064 | $93.90 |
| Q3 2023 | +42,305 | Add 37.75% | 154,369 | $68.22 |
| Q4 2023 | -2,010 | Reduce 1.30% | 152,359 | $73.98 |
| Q1 2024 | +5,398 | Add 3.54% | 157,757 | $69.06 |
| Q2 2024 | +1,447 | Add 0.92% | 159,204 | $42.25 |
| Q3 2024 | -36,302 | Reduce 22.80% | 122,902 | $68.12 |
| Q4 2024 | +53,735 | Add 43.72% | 176,637 | $56.19 |
| Q1 2025 | +9,317 | Add 5.27% | 185,954 | $43.29 |
| Q2 2025 | -27,925 | Reduce 15.02% | 158,029 | $53.14 |
| Q3 2025 | +40,258 | Add 25.48% | 198,287 | $54.71 |
Ken Fisher's Exact Sciences Corporation Investment FAQs
Ken Fisher first purchased Exact Sciences Corporation (EXAS) in Q3 2017, acquiring 6,350 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Exact Sciences Corporation (EXAS) for 33 quarters since Q3 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Exact Sciences Corporation (EXAS) was in Q2 2022, adding 110,755 shares worth $4.36 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 198,287 shares of Exact Sciences Corporation (EXAS), valued at approximately $10.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Exact Sciences Corporation (EXAS) was 198,287 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.